EdgarLookup

Citius Pharmaceuticals, Inc. — 8-K Filings

175 8-K filings on record

This page lists all 8-K filings submitted to the SEC by Citius Pharmaceuticals, Inc. (CTXR), sorted by most recent first. Each row links to the full filing on EdgarLookup. Citius Pharmaceuticals, Inc. has filed 175 8-K documents with the SEC since 2010. To view all SEC filings by Citius Pharmaceuticals, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-KT 10-Q 25-NSE 3 3/A 4 4/A 424B3 424B4 424B5 425 8-A12B 8-A12G 8-K 8-K/A ARS CERTNAS CORRESP CT ORDER D D/A DEF 14A DEFA14A EFFECT FWP NT 10-K NT 10-Q POS AM PRE 14A PRER14A S-1 S-1/A S-3 S-3/A S-3MEF S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
8-K CURRENT REPORT 0001213900-26-025459 Mar 10, 2026
8-K CURRENT REPORT 0001213900-26-023439 Mar 4, 2026
8-K CURRENT REPORT 0001213900-26-015895 Feb 13, 2026 Feb 9, 2026
8-K CURRENT REPORT 0001213900-25-125413 Dec 23, 2025
8-K CURRENT REPORT 0001213900-25-116760 Dec 1, 2025
8-K CURRENT REPORT 0001213900-25-101741 Oct 23, 2025
8-K CURRENT REPORT 0001213900-25-100847 Oct 21, 2025 Oct 20, 2025
8-K CURRENT REPORT 0001213900-25-075034 Aug 12, 2025
8-K CURRENT REPORT 0001213900-25-062099 Jul 8, 2025 Jul 7, 2025
8-K CURRENT REPORT 0001213900-25-053607 Jun 12, 2025 Jun 9, 2025
8-K CURRENT REPORT 0001213900-25-052718 Jun 9, 2025
8-K CURRENT REPORT 0001213900-25-050822 Jun 3, 2025 Jun 2, 2025
8-K CURRENT REPORT 0001213900-25-049550 May 30, 2025 May 29, 2025
8-K CURRENT REPORT 0001213900-25-043362 May 14, 2025
8-K CURRENT REPORT 0001213900-25-033366 Apr 18, 2025 Apr 16, 2025
8-K CURRENT REPORT 0001213900-25-028622 Apr 3, 2025 Mar 28, 2025
8-K CURENT REPORT 0001213900-25-028003 Apr 2, 2025 Apr 1, 2025
8-K CURRENT REPORT 0001213900-25-022237 Mar 10, 2025
8-K CURRENT REPORT 0001213900-25-014359 Feb 14, 2025
8-K CURRENT REPORT 0001213900-25-010747 Feb 6, 2025
8-K CURRENT REPORT 0001213900-25-002071 Jan 8, 2025 Jan 7, 2025
8-K CURRENT REPORT 0001213900-25-001408 Jan 7, 2025
8-K CURRENT REPORT 0001213900-24-113158 Dec 27, 2024
8-K FORM 8-K 0001213900-24-111212 Dec 20, 2024 Dec 18, 2024
8-K CURRENT REPORT 0001213900-24-102833 Nov 26, 2024 Nov 25, 2024
8-K CURRENT REPORT 0001213900-24-102265 Nov 25, 2024
8-K CURRENT REPORT 0001213900-24-099649 Nov 18, 2024 Nov 15, 2024
8-K CURRENT REPORT 0001213900-24-097495 Nov 13, 2024 Nov 6, 2024
8-K CURRENT REPORT 0001213900-24-096268 Nov 12, 2024 Nov 11, 2024
8-K FORM 8-K 0001213900-24-082809 Sep 27, 2024 Sep 25, 2024
8-K CURRENT REPORT 0001213900-24-078288 Sep 13, 2024 Sep 9, 2024
8-K FORM 8-K 0001213900-24-077777 Sep 11, 2024 Sep 10, 2024
8-K CURRENT REPORT 0001213900-24-076108 Sep 5, 2024
8-K CURRENT REPORT 0001213900-24-070285 Aug 16, 2024 Aug 12, 2024
8-K CURRENT REPORT 0001213900-24-067778 Aug 12, 2024
8-K CURRENT REPORT 0001213900-24-066357 Aug 8, 2024
8-K CURRENT REPORT 0001213900-24-045573 May 21, 2024
8-K CURRENT REPORT 0001213900-24-042966 May 14, 2024
8-K CURRENT REPORT 0001213900-24-037861 Apr 30, 2024 Apr 25, 2024
8-K CURRENT REPORT 0001213900-24-030829 Apr 5, 2024 Apr 3, 2024
8-K FORM 8-K 0001213900-24-023483 Mar 18, 2024
8-K CURRENT REPORT 0001213900-24-022184 Mar 13, 2024 Mar 12, 2024
8-K CURRENT REPORT 0001213900-24-014332 Feb 15, 2024 Feb 14, 2024
8-K FORM 8-K 0001213900-24-013676 Feb 14, 2024
8-K CURRENT REPORT 0001213900-24-005727 Jan 23, 2024
8-K CURRENT REPORT 0001213900-24-001508 Jan 5, 2024 Jan 4, 2024
8-K CURRENT REPORT 0001213900-24-000247 Jan 2, 2024
8-K CURRENT REPORT 0001013762-23-006005 Oct 24, 2023 Oct 23, 2023
8-K CURRENT REPORT 0001213900-23-079162 Sep 25, 2023
8-K CURRENT REPORT 0001213900-23-077043 Sep 15, 2023 Sep 12, 2023